Author | Saeed Rafii, MD, PhD | OncLive

Author | Saeed Rafii, MD, PhD

Articles

Dr. Rafii on Future Immunotherapy Approaches for Patients With Bladder Cancer

September 02, 2016

Video

Saeed Rafii, MD, PhD, medical director, Sarah Cannon Research Institute, United Kingdom, discusses novel immunotherapy approaches for the treatment of patients with bladder cancer.

Dr. Rafii on Durvalumab in Patients With Urothelial Bladder Cancer

June 14, 2016

Video

Saeed Rafii, MD, PhD, medical director, Sarah Cannon Research Institute, United Kingdom, discusses a phase I/II dose-escalation study examining the efficacy and safety of the PD-1 antibody durvalumab in patients with metastatic urothelial bladder cancer.

Dr. Saeed Rafii on Atezolizumab/ Nab-paclitaxel in TNBC

December 11, 2015

Video

Saeed Rafii, MD, PhD, medical director, Sarah Cannon Research Institute United Kingdom, discusses a study evaluating the safety and clinical activity of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer (TNBC).

Dr. Rafii Discusses Clinical Outcomes With Olaparib in Patients with Ovarian Cancer

June 16, 2015

Video

Saeed Rafii, MD, PhD, MRCP, medical director, Sarah Cannon Research Institute, discusses factors that influence clinical outcomes to olaparib in patients with BRCA1/2-mutant ovarian cancer.

x